Latest news

Annual Report 2017

Posted on Mar 19, 2018

Oslo, Norway, March 19, 2018 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2017 and the report is attached. The Annual Report 2017 is also available on the company’s website (Annual reports). PCI Biotech Holding ASA Annual Report 2017 For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen […]

Invitation to full year 2017 presentation

Posted on Mar 13, 2018

Oslo, 13 March 2018 – PCI Biotech invites to a presentation of the company’s full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am – 09:30am CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo […]

PCI Biotech to present at Bio-Europe Spring 2018

Posted on Mar 12, 2018

Oslo, Norway, March 12, 2018 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Bio-Europe Spring 2018 being held March 12-14, 2018 at the Amsterdam RAI Convention Center, Amsterdam, The Netherlands. On Wednesday, March 14, 2018 at 10:15am (CET), Mr. Gaël L’Hévéder, […]